Germline BAP1 mutations predispose also to multiple basal cell carcinomas

Clinical Genetics

Volumn 88, Issue 3, 2015, Pages 273-277

  de la Fouchardière, Arnaud ^a   Cabaret, O ^b   Savin, L ^c   Combemale, P ^a   Schvartz, H ^d   Penet, C ^e   Bonadona, V ^a   Soufir, N ^f   Bressac de Paillerets, B ^b  

^a CENTRE LÉON BÉRARD   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Polyclinique de Courlancy   (France)

^d Pathologie   (France)

^e Institut du Cancer Courlancy   (France)

^f BICHAT HOSPITAL   (France)

Author keywords

BAP1 cancer syndrome; Basal cell carcinoma; Genetics; Skin cancer

Indexed keywords

BRCA1 ASSOCIATED PROTEIN 1; DEUBIQUITINASE; MELANOCORTIN 1 RECEPTOR; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ADULT; ALLELE; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ELASTOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GERMLINE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE CANCER; NODULAR BASAL CELL CARCINOMA; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUN EXPOSURE; SUPERFICIAL BASAL CELL CARCINOMA; CARCINOMA, BASAL CELL; CASE CONTROL STUDY; GENETICS; GENOTYPE; HAMARTOMA SYNDROME, MULTIPLE; METABOLISM; PEDIGREE; PHENOTYPE;

ADULT; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; RECEPTOR, MELANOCORTIN, TYPE 1; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84938877109     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12472     Document Type: Article

References (25)

1. Jensen DE, Proctor M, Marquis ST et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998: 16 (9): 1097-1112.
2. Jensen DE, Rauscher FJ III. BAP1, a candidate tumor suppressor protein that interacts with BRCA1. Ann N Y Acad Sci 1999: 886: 191-194.
3. Eletr ZM, Wilkinson KD. An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem Biophys 2011: 60 (1-2): 3-11.
4. Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 2009: 284 (49): 34179-34188.
5. Yu H, Mashtalir N, Daou S et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 2010: 30 (21): 5071-5085.
6. Testa JR, Cheung M, Pei J et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011: 43 (10): 1022-1025.
7. Murali R, Wiesner T, Scolyer RA. Tumours associated with BAP1 mutations. Pathology 2013: 45 (2): 116-126.
8. Goldstein AM. Germline BAP1 mutations and tumor susceptibility. Nat Genet 2011: 43 (10): 925-926.
9. Aoude LG, Wadt K, Bojesen A et al. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PLoS One 2013: 8 (8): e72144.
10. Busam KJ, Wanna M, Wiesner T. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. JAMA Dermatol 2013: 149 (3): 335-339.
11. Carbone M, Ferris LK, Baumann F et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 2012: 10: 179.
12. Wiesner T, Obenauf AC, Murali R et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011: 43 (10): 1018-1021.
13. Abdel-Rahman MH, Pilarski R, Cebulla CM et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011: 48 (12): 856-859.
14. Njauw CN, Kim I, Piris A et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 2012: 7 (4): e35295.
15. Popova T, Hebert L, Jacquemin V et al. Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 2013: 92 (6): 974-980.
16. Griewank KG, van de Nes J, Schilling B et al. Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Mod Pathol 2014: 27 (2): 175-183.
17. Harbour JW, Onken MD, Roberson ED et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010: 330 (6009): 1410-1413.
18. Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012: 44 (7): 751-759.
19. Khalesi M, Whiteman DC, Doi SA, Clark J, Kimlin MG, Neale RE. Cutaneous markers of photo-damage and risk of Basal cell carcinoma of the skin: a meta-analysis Cancer Epidemiol Biomarkers Prev 2013: 22 (9): 1483-1489.
20. Liboutet M, Portela M, Delestaing G et al. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 2006: 126 (7): 1510-1517.
21. Scherer D, Bermejo JL, Rudnai P et al. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int J Cancer 2008: 122 (8): 1787-1793.
22. ® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014.2002 Jun 20 [updated 2013 Mar 07].
23. Situm M, Buljan M, Cavka V, Bulat V, Krolo I, Mihic LL. Skin changes in the elderly people - how strong is the influence of the UV radiation on skin aging? Coll Antropol 2010: 34 (Suppl. 2): 9-13.
24. Stokes MP, Rush J, MacNeill J et al. Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A 2007: 104 (50): 19855-19860.
25. Matsuoka S, Ballif BA, Smogorzewska A et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007: 316 (5828): 1160-1166.